[1] 胡志明. 128 例药物性肝病分析. 中国当代医药, 2012,19:21-22.
[2] 朱欣欣,万朝敏. 药物性肝损害研究进展.中国实用儿科杂志, 2011, 11:865-867.
[3] 刘鸿凌, 尹明红, 游绍莉, 等. 甘草酸制剂治疗药物性肝损害患者疗效观察. 实用肝脏杂志, 2013,16:257-258.
[4] 邱曙光,刘康栋,董子明. 柳氮磺胺吡啶引起药物超敏反应综合征一例临床分析.药物研究
[5] Ganeva M, Gancheva T, Lazarova R, et al. Carbamazepine-in-duced drug reaction with eosinophilia and systemic symptoms(DRESS) syndrome: report of four cases and brief review. IntJ Dermatol, 2008, 47:853-860.
[6] 胡玲,王琼.药物超敏反应综合征2例.临床皮肤科杂志,2016, 45:650-651.
[7] 李兴天,刘莉萍,李遇梅.柳氮磺吡啶致药物超敏反应综合征. 临床皮肤科杂志,2014 43:421-422.
[8] 万学峰,王珊珊,陈永琴.别嘌醇致药物超敏反应综合征 1例.临床皮肤科杂志,2010,39:131.
[9] Shiohara T,Kano Y,Takahashi R,et al. Drug-induced hyper sensitivity syndrome:recent advances in the diagnosis,patho genesis and management. Chem Immunol Allergy,2012,97:122-138.
[10] Shiohara T, Inaoka M, Kano Y. Drug -induced hypersensitivitysyndrome (DIHS):a reaction induced by a complex interplay a-mong herpesviruses and anti-drug immune responses. Allergol Int, 2006, 55:1-8.
[11] Gentile I, Talamo M, Borgia G. Is the drug-induced hypersensi-tivity syndrome (DIHS) due to herpesvirus 6 infection or to al-lergy-mediated viral reactivation report of a case and literaturereview. BMC Infectious Dis, 2010, 10:49.
[12] 张学军.皮肤性病学.7 版.北京:人民卫生出版社,2008:124-125. |
